Amgen

Back to Search
505 9th Street NW, Suite 600
Washington, DC MD 20004
Share:
Member News
Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint
Horizon Therapeutics plc Announces Inaugural #RAREis Global Advocate Grant Recipients
Powered By GrowthZone

MDLS
NEW MEMBERS

LEARN ABOUT MARYLAND
LIFE SCIENCES

LEARN MORE